Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Free Report) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 5,800 shares, an increase of 20.8% from the November 15th total of 4,800 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 58.0 days.
Analyst Upgrades and Downgrades
Separately, Wolfe Research upgraded Sartorius Aktiengesellschaft to a “strong-buy” rating in a research note on Thursday, November 14th.
Read Our Latest Analysis on SARTF
Sartorius Aktiengesellschaft Price Performance
Sartorius Aktiengesellschaft (OTCMKTS:SARTF – Get Free Report) last posted its quarterly earnings results on Thursday, October 17th. The company reported $0.96 earnings per share (EPS) for the quarter. Sartorius Aktiengesellschaft had a return on equity of 7.69% and a net margin of 2.50%. The business had revenue of $872.19 million for the quarter.
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers.
Further Reading
- Five stocks we like better than Sartorius Aktiengesellschaft
- The Role Economic Reports Play in a Successful Investment Strategy
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Special Dividend?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Retail Stocks Investing, Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Sartorius Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.